This opportunity is no longer accepting applications.
grant PAR-24-029

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

This grant opportunity aims to support the creation of a detailed plan for developing new treatments and preventive strategies for HIV and related health issues. It also helps in translating research into drug products suitable for submitting an Investigational New Drug (IND) application to the FDA.

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as wel…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR

Awards & funding

Award Ceiling: $225,000
Award Amount: $225,000

Dates

Opportunity Released: August 14, 2023
Open for Submission: August 14, 2023
Submission Deadline: December 4, 2026
Application Window Closes: December 4, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.